Literature DB >> 10976409

The potential use of maturation in vitro of human oocytes in low responder patients.

A Requena1, F Neuspiller, A C Cobo, M Aragonés, J Remohí, C Simón, A Pellicer.   

Abstract

PURPOSE: To assess whether maturation in vitro of human oocytes (MIVHO) could be an alternative treatment in low responders to ovarian stimulation for in vitro fertilization (IVF).
METHODS: Prospective case-control study. Spontaneously ovulatory women who volunteered were included in our program of MIVHO at the Instituto Valenciano de Infertilidad. Rates of oocyte retrieval, in vitro maturation, fertilization, and development up to the blastocyst stage were studied.
RESULTS: A significantly increased rate of oocyte retrieval was found when the pickup was performed before follicular selection. No differences were found when MIVHO was used in a low responder patient with an ovarian content of early antral follicles > 5 as compared to normal responders.
CONCLUSIONS: MIVHO could be a successful choice in low responder patients with an acceptable number of early antral follicles. Oocyte retrieval should be performed before follicular selection in order to obtain more oocytes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10976409      PMCID: PMC3455207          DOI: 10.1023/a:1009405730750

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  23 in total

1.  Maturation in vitro of human oocytes from unstimulated cycles: selection of the optimal day for ovum retrieval based on follicular size.

Authors:  A C Cobo; A Requena; F Neuspiller; M Aragon s; A Mercader; J Navarro; C Simón; J Remohí; A Pellicer
Journal:  Hum Reprod       Date:  1999-07       Impact factor: 6.918

2.  Embryonic regulation of integrins beta 3, alpha 4, and alpha 1 in human endometrial epithelial cells in vitro.

Authors:  C Simón; M J Gimeno; A Mercader; J E O'Connor; J Remohí; M L Polan; A Pellicer
Journal:  J Clin Endocrinol Metab       Date:  1997-08       Impact factor: 5.958

3.  Intracytoplasmic testicular sperm injection: an effective treatment for otherwise intractable obstructive azoospermia.

Authors:  M Gil-Salom; Y Minguez; C Rubio; J Remohi; A Pellicer
Journal:  J Urol       Date:  1995-12       Impact factor: 7.450

Review 4.  The application of transvaginal ultrasound for ovulation induction and in vitro fertilization.

Authors:  M J Nachtigall; L B Schwartz
Journal:  Clin Obstet Gynecol       Date:  1996-03       Impact factor: 2.190

5.  Use of the antral follicle count to predict the outcome of assisted reproductive technologies.

Authors:  M Y Chang; C H Chiang; T T Hsieh; Y K Soong; K H Hsu
Journal:  Fertil Steril       Date:  1998-03       Impact factor: 7.329

6.  In vitro maturation and the fertilization and developmental competence of oocytes recovered from untreated polycystic ovarian patients.

Authors:  A Trounson; C Wood; A Kausche
Journal:  Fertil Steril       Date:  1994-08       Impact factor: 7.329

7.  Immature oocyte retrieval: lessons from unstimulated IVF cycles.

Authors:  M H Thornton; M M Francis; R J Paulson
Journal:  Fertil Steril       Date:  1998-10       Impact factor: 7.329

8.  Evaluation of the ovarian reserve in young low responders with normal basal levels of follicle-stimulating hormone using three-dimensional ultrasonography.

Authors:  A Pellicer; G Ardiles; F Neuspiller; J Remohí; C Simón; F Bonilla-Musoles
Journal:  Fertil Steril       Date:  1998-10       Impact factor: 7.329

9.  Pregnancy and birth rates after oocyte donation.

Authors:  J Remohí; B Gartner; E Gallardo; S Yalil; C Simón; A Pellicer
Journal:  Fertil Steril       Date:  1997-04       Impact factor: 7.329

10.  Gonadotropin-binding sites in the rhesus monkey ovary: role of the vasculature in the selective distribution of human chorionic gonadotropin to the preovulatory follicle.

Authors:  A J Zeleznik; H M Schuler; L E Reichert
Journal:  Endocrinology       Date:  1981-08       Impact factor: 4.736

View more
  1 in total

1.  Interval double transfer improves treatment success in patients with repeated IVF/ET failures.

Authors:  B Almog; I Levin; I Wagman; R Kapustiansky; T Schwartz; N Mey-Raz; A Amit; F Azem
Journal:  J Assist Reprod Genet       Date:  2008-08-14       Impact factor: 3.412

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.